1 / 20

Design of a Well-Mix Reactor to Convert Insulin-Precursor to Crude Insulin via Transpeptidation

Design of a Well-Mix Reactor to Convert Insulin-Precursor to Crude Insulin via Transpeptidation. Monday, April 3, 2006 8:30-9:30am. Presented by: Andrea Evans Rob Galloway Imran Ratanshi Department of Chemical Engineering Queen’s University, Kingston, ON.

sage
Télécharger la présentation

Design of a Well-Mix Reactor to Convert Insulin-Precursor to Crude Insulin via Transpeptidation

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Design of a Well-Mix Reactor to Convert Insulin-Precursor to Crude Insulin via Transpeptidation Monday, April 3, 2006 8:30-9:30am Presented by: Andrea Evans Rob Galloway Imran Ratanshi Department of Chemical Engineering Queen’s University, Kingston, ON Well-Mix Reactor Design

  2. Overview • Background • Reactor Options • Reaction Kinetics • Design Methodology • Recommended Size • Costs • Process Alternatives • Conclusions • References • Questions

  3. Insulin Production Process Figure 1. Proposed recombinant human insulin production process.

  4. Background • Our Reaction Insulin Precursor Crude Insulin + “Denatured” Insulin (90%) (10%) • Aqueous reaction • Other info: • 100% Yield • Reaction is catalyzed by Trypsin transpeptidation

  5. The Reaction • Enzyme Trypsin cleaves precursor after: • 29th Amino acid (Lysine) of B-chain • 22nd Amino acid (Glycine) of A chain • Cleavage at alternate site (Gly-Arg) results in ‘denatured form) • 10% of output product

  6. Reactor Options • Batch vs. Continuous

  7. Reactor Options • Want to avoid cleavage of insulin at secondary site by avoiding product inhibition • Use Batch reactor

  8. Process Specifications • Reactor Yield ~ 100% • Overall process output = 44 kg/batch • Neglect insulin ‘defolding’ and ‘refolding’ unit operations • Assume fermentor operation was process limiting • Reactor operating time should be < 60hrs • Reactor Input = 45% (w/v) • Assume complete dissolution of insulin precursor • Fluid density ~ 1kg/L

  9. Reaction Kinetics • Enzymatic reaction [E] + [S] [ES] [E] + [P] - Michaelis-Mention Kinetics • Vmax = Maximum Conversion Rate (Enzyme saturation) • Vmax = k2[ET] • Km = Michaelis-Menton Constant (Measure of binding) • [S] = Substrate Concentration (Insulin precursor) • Assumptions: • No Competitive/Non-competitive Inhibition k1 k2

  10. Design Methodology • Batch process (Fogler, 1999): • General Mole Balance Equation • Combine with Rate Expression

  11. Design Methodology 3. Separate variables and solve for time t • Process Parameters (Schilling and Mitra, 1991) • Vmax = f ([ET]) = 1.41 x 10-5M min-1 • Km = 9.9 x 10-5M

  12. Design Methodology • To produce 11.31kg, Petrides (2000) required a fluid volume of 4,300L to convert insulin precursor to crude human insulin • E.coli (intracellular) production process • To produce ~44kg, we scaled up this volume by a factor of 4 • Approximate fluid volume is 17,200L

  13. Design Summary Table 1. Summary of reactor design parameters.

  14. Reaction Time Figure 2. Plot of insulin precursor concentration as a function of time.

  15. Cost Analysis • Perry’s Chemical Engineering Handbook • q1= 100 US Gal q2= 5679.7 US Gal C1= $9300 (US) n= 0.53 Therefore C2= $79118

  16. Cost Analysis • Problems with this model: • Oversimplification by correlating in terms of a single variable • Simple exponential relationship • Fails to include technological improvement • Reactor modeled as a carbon steel reactor instead of stainless steel

  17. Cost Analysis • ChemEcon • Modeled as a stainless steel vessel • Height (m) = 4.78 • Diameter (m) = 2.39 • Pressure (bar) = 1.013 • Bare Module Cost = $152 067

  18. Cost Analysis • SuperPro Designer • Purchase Cost = $100 578 • Unit Cost = $101 000 • Operating Hours = 120 hours/year • Power = 4.9 kW • Annual = 11703 kWh • Cost of Power = $1000/year at 10 cents/kWh

  19. Process Alternatives • Enzymatic decomposition of proinsulin by trypsin. In large-scale production it is more economical to use immobilized enzymes.

  20. References • Fogler, S.H. Elements of Chemical Reaction Engineering, 3rd Ed. Prentice Hall. New Jersey. (1999). 1-393. • Kudryavtseva, N.E. and L. S. Zhigis, V. P. Zubov, A. N. Vul'fson, K. V. Mal'tsev and L. D. Rumsh. Immobilization of trypsin and carboxypeptidase B on modified silicas and their use in converting human recombinant proinsulin into insulin. Pharmaceutical Chemistry Journal. 29:1 (1995) 70-73 • Petrides, D. Bioprocess Design. Intelligen, Inc. • Schilling, R.J. and A.K. Mitra. Degradation of insulin by trypsin and alpha-chymotrypsin. Pharmaceutical Research. 8:6 (1991) 721-727

More Related